06/15/2023—AcePre LLC received a Notice of Award from National Institute of Allergy and Infectious Diseases (NIAID) for the project entitled “Targeting macrophage maladaptation for bacterial sepsis treatment”. This project entails collaboration between Wake Forest University and AcePre LLC. The total NIAID funding for this project is $597,310.00; the funding period is 06/15/2023-05/31/2025.

03/14/2023—AcePre LLC received a Notice of Award from National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the project entitled “Developing natural compound emodin as a therapy for alcoholic cardiomyopathy”. This project is a collaborative effort between University of South Carolina and AcePre LLC. The total funding for this project is $918,358.00; the funding period is 03/15/2023-02/28/2025.